Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells - PubMed (original) (raw)
. 2001 Apr 1;61(7):3194-9.
Affiliations
- PMID: 11306508
Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells
D A Fishman et al. Cancer Res. 2001.
Abstract
Ovarian cancer is an highly metastatic disease characterized by ascites formation and diffuse i.p. adhesion, invasion, and metastasis. Levels of lysophosphatidic acid (LPA) are elevated in the plasma of patients with ovarian carcinoma, including 90% of patients with stage I disease, suggesting that LPA may promote early events in ovarian carcinoma dissemination. Expression of matrix metalloproteinases (MMPs) is also up-regulated in ovarian cancer tissues and ascites, and numerous studies have provided evidence for a direct role of MMPs in i.p. invasion and metastasis. Using three-dimensional type I collagen cultures or immobilized beta1 integrin subunit-specific antibodies, we previously demonstrated that beta1 integrin clustering promotes activation of proMMP-2 and processing of membrane type 1 MMP in ovarian cancer cells (S. M. Ellerbroek et al., Cancer Res., 59: 1635-1641, 1999). In the current study, the effect of LPA on MMP expression and invasive activity was investigated. Treatment of ovarian cancer cells with pathophysiological levels of LPA increased cellular adhesion to type I collagen and beta1 integrin expression. A significant up-regulation of MMP-dependent proMMP-2 activation was observed in LPA-treated cells, leading to enhanced pericellular MMP activity. As a result of increased MMP activity, haptotactic and chemotactic motility, in vitro wound closure, and invasion of a synthetic basement membrane were enhanced. These data indicate that LPA contributes to metastatic dissemination of ovarian cancer cells via up-regulation of MMP activity and subsequent downstream changes in MMP-dependent migratory and invasive behavior.
Similar articles
- Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.
Symowicz J, Adley BP, Woo MM, Auersperg N, Hudson LG, Stack MS. Symowicz J, et al. Cancer Res. 2005 Mar 15;65(6):2234-42. doi: 10.1158/0008.5472.CAN-04-2781. Cancer Res. 2005. PMID: 15781636 - Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
Wang FQ, Ariztia EV, Boyd LR, Horton FR, Smicun Y, Hetherington JA, Smith PJ, Fishman DA. Wang FQ, et al. Gynecol Oncol. 2010 Apr;117(1):88-95. doi: 10.1016/j.ygyno.2009.12.012. Epub 2010 Jan 6. Gynecol Oncol. 2010. PMID: 20056268 - Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.
So J, Navari J, Wang FQ, Fishman DA. So J, et al. Gynecol Oncol. 2004 Nov;95(2):314-22. doi: 10.1016/j.ygyno.2004.08.001. Gynecol Oncol. 2004. PMID: 15491751 - Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
Sato H, Okada Y, Seiki M. Sato H, et al. Thromb Haemost. 1997 Jul;78(1):497-500. Thromb Haemost. 1997. PMID: 9198203 Review. - Cell surface activation of progelatinase A (proMMP-2) and cell migration.
Nagase H. Nagase H. Cell Res. 1998 Sep;8(3):179-86. doi: 10.1038/cr.1998.18. Cell Res. 1998. PMID: 9791731 Review.
Cited by
- The Role of EMT-Related lncRNAs in Ovarian Cancer.
Lampropoulou DI, Papadimitriou M, Papadimitriou C, Filippou D, Kourlaba G, Aravantinos G, Gazouli M. Lampropoulou DI, et al. Int J Mol Sci. 2023 Jun 13;24(12):10079. doi: 10.3390/ijms241210079. Int J Mol Sci. 2023. PMID: 37373222 Free PMC article. Review. - Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics.
Chen M, Lei N, Tian W, Li Y, Chang L. Chen M, et al. Ther Adv Med Oncol. 2022 Aug 12;14:17588359221118010. doi: 10.1177/17588359221118010. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35983027 Free PMC article. Review. - The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer.
Cunningham R, Hansen CG. Cunningham R, et al. Clin Sci (Lond). 2022 Feb 11;136(3):197-222. doi: 10.1042/CS20201474. Clin Sci (Lond). 2022. PMID: 35119068 Free PMC article. Review. - The role of MMP-14 in ovarian cancer: a systematic review.
Vos MC, van der Wurff AAM, van Kuppevelt TH, Massuger LFAG. Vos MC, et al. J Ovarian Res. 2021 Aug 3;14(1):101. doi: 10.1186/s13048-021-00852-7. J Ovarian Res. 2021. PMID: 34344453 Free PMC article. - The Role of Platelet Cell Surface P-Selectin for the Direct Platelet-Tumor Cell Contact During Metastasis Formation in Human Tumors.
Fabricius HÅ, Starzonek S, Lange T. Fabricius HÅ, et al. Front Oncol. 2021 Mar 15;11:642761. doi: 10.3389/fonc.2021.642761. eCollection 2021. Front Oncol. 2021. PMID: 33791226 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous